CorMedix Inc. Files Definitive Proxy Statement

TL;DR

CorMedix proxy filed - vote on directors & auditors.

AI Summary

CorMedix Inc. filed its definitive proxy statement on October 8, 2024, for its annual meeting of stockholders. The filing outlines the proposals to be voted on, including the election of directors and the ratification of the appointment of its independent registered public accounting firm. The company is seeking shareholder approval for these matters to ensure continued corporate governance and financial oversight.

Why It Matters

This filing is crucial for shareholders as it details the agenda for the annual meeting, allowing them to make informed decisions on company leadership and financial auditing.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) that outlines upcoming shareholder votes and does not contain new material financial information or strategic changes.

Key Players & Entities

• CorMedix Inc. (company) — Registrant
• 0001213900-24-086301 (filing_id) — Accession Number
• 20241008 (date) — Filing Date
• 20241121 (date) — Fiscal Year End

FAQ

Filing Documents

• ea0216921-01.htm (DEF 14A) — 1647KB
• tbarchart_001.jpg (GRAPHIC) — 351KB
• tbarchart_002.jpg (GRAPHIC) — 343KB
• tproxy_001.jpg (GRAPHIC) — 1019KB
• tproxy_002.jpg (GRAPHIC) — 971KB
• 0001213900-24-086301.txt ( ) — 5346KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT   33 DIRECTOR COMPENSATION   35

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION   37 AUDITOR AND AUDIT COMMITTEE MATTERS   45 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS   46 STOCKHOLDER COMMUNICATIONS   46 DEADLINE FOR STOCKHOLDER PROPOSALS FOR 2025 ANNUAL MEETING   46 DELIVERY OF DOCUMENTS TO STOCKHOLDERS SHARING AN ADDRESS   47 ANNUAL REPORT ON FORM 10-K   47 INSTRUCTIONS TO CORMEDIX INC. 2024 VIRTUAL ANNUAL MEETING   47 i Table of Contents CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS Certain statements in this proxy statement for the 2024 Annual Meeting of Stockholders, including the documents that we incorporate by reference, contain “forward -looking statements” that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward -looking statements. The statements contained in this proxy statement that are not purely historical are forward -looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward -looking statements are often identified by the use of words such as, but not limited to, “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “will,” “plan,” “project,” “seek,” “should,” “target,” “will,” “would,” and similar expressions or variations intended to identify forward -looking statements. Such statements are based on management&#x201

View Full Filing

View this DEF 14A filing on SEC EDGAR